Diabetic Retinopathy
![Roche drops eye drug, exits solid tumor field](https://pharmtales.com/wp-content/uploads/2023/10/Roche-abandons-oral-drug-for-eye-disease-after-phase-2-failure-shifts-focus-from-solid-tumor-bispecifics-1.jpg)
Roche abandons oral drug for eye disease after phase 2 failure, shifts focus from solid tumor bispecifics
Anika Sharma
Roche’s ambitious quest to develop an oral treatment for diabetic retinopathy has faced a setback, as the company decided to ...